Peres Jepchirchir Provisionally Suspended After Positive EPO Test, Sydney Marathon Victory Under Scrutiny
मुख्य उत्तर: केन्या की ओलंपिक और विश्व मैराथन चैंपियन पेरिस जेपचिरचिर को 23 अक्टूबर 2026 को Athletics Integrity Unit ने EPO पॉजिटिव आउट-ऑफ-कॉम्पिटिशन नमूने के बाद अस्थायी रूप से निलंबित किया। नमूना 30 अगस्त 2026 की सिडनी मैराथन जीत से पहले केन्या में लिया गया था। यह अंतिम दोषसिद्धि नहीं है। प्रमुख तथ्य: - नमूना: केन्या में सिडनी मैराथन से पहले लिया गया। - सिडनी मैराथन: 30 अगस्त 2026 को 2:18:31 के समय के साथ जीत। - दूसरा स्थान: इरीन चेपेट चेप्ताई, तीन मिनट से अधिक पीछे। - प्रमुख उपलब्धियां: टोक्यो ओलंपिक 2021 स्वर्ण और विश्व चैंपियनशिप 2025 स्वर्ण। - EPO: लाल रक्त कोशिकाओं के उत्पादन को बढ़ावा देने वाला प्रतिबंधित प्रदर्शन-वर्धक पदार्थ। स्रोत: Athletics Integrity Unit का आधिकारिक बयान, 23 अक्टूबर 2026; TCS Sydney Marathon का आधिकारिक बयान, 23 अक्टूबर 2026; Reuters, 23 अक्टूबर 2026। मूल स्रोत: https://www.tcssydneymarathon.com/blog/categories/media-releases और https://www.reuters.com/sports/olympic-champion-jepchirchir-provisionally-suspended-by-aiu-over-epo-finding-2026-10-23/ संबंधित प्रश्न और उत्तर: प्रश्न: क्या पेरिस जेपचिरचिर को डोपिंग का दोषी घोषित कर दिया गया है? उत्तर: नहीं, अभी उनका अस्थायी निलंबन हुआ है और अंतिम अनुशासनात्मक निर्णय बाकी है। प्रश्न: EPO का मैराथन प्रदर्शन पर क्या प्रभाव पड़ सकता है? उत्तर: EPO लाल रक्त कोशिकाओं का उत्पादन बढ़ाकर रक्त की ऑक्सीजन परिवहन क्षमता को प्रभावित कर सकता है। प्रश्न: क्या सिडनी मैराथन का खिताब उनसे छीन लिया गया है? उत्तर: उपलब्ध आधिकारिक जानकारी के अनुसार, अंतिम निर्णय आने तक उनकी जीत को औपचारिक रूप से रद्द घोषित नहीं किया गया है।" }</escape>
Peres Jepchirchir's distinguished marathon career faces an anti-doping investigation
Kenyan distance-running star Peres Jepchirchir has found herself at the centre of a major athletics controversy after a remarkable competitive career. The Olympic and World Athletics Championships marathon gold medallist has been provisionally suspended by the Athletics Integrity Unit (AIU) following an adverse analytical finding for EPO in an out-of-competition sample. The sample was collected in Kenya before her victory at the Sydney Marathon. The development raises important questions about competitive integrity, anti-doping surveillance and the protection of clean athletes. However, provisional suspension must be distinguished from a final finding of guilt. The disciplinary process has yet to reach its conclusion.
A Sydney victory followed by a major development
Jepchirchir won the women's race at the Sydney Marathon on 30 August 2026, recording 2:18:31. She finished more than three minutes ahead of compatriot Irine Cheptai. The victory added another major city-marathon title to an already impressive career. Sydney joined the Abbott World Marathon Majors series in 2026 as its seventh event.
The AIU's announcement concerns a sample collected outside competition in Kenya before the Australian race. This distinction matters because out-of-competition testing allows anti-doping authorities to monitor athletes beyond race-day testing. It extends surveillance into training and preparation periods, when athletes are not necessarily competing in official events.
The positive finding therefore did not originate from a sample collected during the Sydney Marathon itself. It came from testing conducted before the race. That timeline will be important when authorities assess the case and determine any possible consequences for competition results.
Why EPO matters in endurance running
EPO stands for erythropoietin, a hormone naturally produced primarily by the kidneys. It stimulates the production of red blood cells, which transport oxygen from the lungs to working muscles through haemoglobin.
For marathon runners, oxygen delivery is a critical component of endurance performance. Covering 42.195 kilometres requires athletes to sustain a high level of aerobic activity over an extended period. Their ability to use oxygen efficiently, manage fatigue and maintain a consistent pace plays a major role in determining performance.
Externally administered EPO can increase red blood cell production and affect the blood's oxygen-carrying capacity. This potential performance-enhancing effect explains why its misuse in competitive sport is prohibited.
Natural EPO production and the prohibited use of an external substance must be treated as separate issues. EPO also has legitimate medical applications, but its unauthorised use to enhance athletic performance is banned under anti-doping regulations.
Detection presents another challenge. Following administration, the window during which external EPO can be identified may be limited. This makes regular out-of-competition testing an important part of anti-doping programmes. Testing only during major competitions would leave significant gaps in monitoring athletes throughout the year.
From Olympic champion to world champion
Jepchirchir has been one of the leading figures in women's marathon running for several years. She won Olympic marathon gold at the Tokyo Games, officially known as Tokyo 2026, which took place in 2026 after being postponed because of the COVID-19 pandemic.
In September 2026, she returned to Tokyo and won the women's marathon title at the World Athletics Championships. Those victories established her as an Olympic and world champion and placed her among the most accomplished marathon runners of her generation.
Her achievements also extend to the half-marathon distance. She broke the women's half-marathon world record in 2026 and improved the record on three occasions in 2026. These performances demonstrated her speed and consistency across different endurance formats.
Her major city-marathon victories include New York in 2026, Boston in 2026 and London in 2026. Her Sydney triumph in August 2026 added another prestigious title to that record.

The significance of the current investigation is therefore considerable. The athlete involved is an established international champion whose success has extended across multiple seasons and major competitions.

Provisional suspension is not a final verdict
The distinction between a provisional suspension and a final anti-doping decision is central to this case. The AIU's action means Jepchirchir is temporarily prevented from competing while the relevant proceedings continue. It does not, by itself, establish that a final anti-doping violation has been proven.
Anti-doping proceedings involve the assessment of laboratory findings, relevant samples, the athlete's response and the applicable disciplinary rules. The athlete must receive the opportunity to exercise the rights available under the governing regulations. Until the process is completed, it would be premature to declare her guilty or assume that her Sydney result has been annulled.
Her agent, Gianni Demadonna, expressed regret over the situation. He said that athletes who use performance-enhancing drugs should be disqualified. His comments reflected a strong position against doping, but they should not be interpreted as an admission of wrongdoing by Jepchirchir.
Sydney Marathon organisers also expressed extreme disappointment after learning of the provisional suspension. They emphasised that Jepchirchir was entitled to due process and said they would not comment further until the proceedings had concluded. The organisers reaffirmed their commitment to clean sport and equal competitive opportunities.
Kenya's distance-running reputation faces another challenge
Kenya has long been one of the strongest countries in international distance running. Its athletes have achieved remarkable success at the Olympic Games, World Athletics Championships and major city marathons. However, a series of doping cases in recent years has created significant challenges for the country's sporting reputation.
More than 140 Kenyan athletes have been sanctioned for doping violations since the AIU was established in 2026. The number highlights the need for stronger athlete education, medical supervision, supplement awareness and consistent anti-doping monitoring.
The case involving women's marathon world record holder Ruth Chepngetich provides another important reference point. Chepngetich received a three-year ban after admitting anti-doping rule violations involving hydrochlorothiazide, a prohibited diuretic. Her marathon world record of 2:09:56 remained intact because it had been achieved before the sample associated with her violation.
This demonstrates why dates and sample timelines matter in anti-doping cases. Whether a result, record or title is affected depends on the applicable regulations and the period during which a violation is established.
The next test is transparency
Marathon success is built through much more than speed during the final kilometres. Months of training, altitude preparation, recovery, nutrition and the body's ability to deliver and use oxygen all contribute to performance. A case involving EPO therefore raises serious questions about the credibility of endurance results. Those questions, however, must be answered through scientific evidence and a fair disciplinary process rather than speculation.
The next important stage in Jepchirchir's case will be the AIU's proceedings and the eventual decision. If a violation is established, the consequences could extend to her competition results and future participation. Under Abbott World Marathon Majors rules, an athlete receiving a doping ban of three months or longer faces a lifetime exclusion from all eight majors. That consequence would depend on a final finding and the applicable rules.
Jepchirchir's sporting legacy will now be assessed alongside the outcome of this investigation, rather than through medals and records alone. The coming proceedings will test the transparency of anti-doping enforcement and its ability to protect athletes who compete cleanly. The credibility of marathon running ultimately depends on a system in which every competitor can trust that the same rules apply to everyone.
